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Abstract: It is known that respiratory muscles undergo adaptation in response to overload 
stimuli during exercise training in stable COPD patients, thus resulting in signiﬁ  cant increase 
of respiratory muscle function as well as the individual’s improvements. The present article 
reviews the most updated evidence with regard to the use of respiratory muscle training 
(RMT) methods in COPD patients. Basically, three types of RMT (resistive training, pressure 
threshold loading, and normocapnic hyperpnea) have been reported. Frequency, duration, 
and intensity of exercise must be carefully considered for a training effect. In contrast with 
the plentitude of existing data inherent to inspiratory muscle training (IMT), literature is still 
lacking in showing clinical and physiological studies related to expiratory muscle training 
(EMT). In particular, while it seems that IMT is slightly superior to EMT in providing ad-
ditional beneﬁ  ts other than respiratory muscle function such as a reduction in dyspnea, both 
the effects and the safety of EMT is still to be deﬁ  nitively elucidated in patients with COPD.
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Rationale 
Systemic inﬂ  ammation is now known to be an important aspect of chronic obstructive 
pulmonary disease (COPD) which is able to extend its effects to the skeletal muscular 
structure. Even if this muscular dysfunction does not similarly involve all the periph-
eral muscles, available evidence suggests that respiratory muscles are almost always 
involved (Gosselink et al 2000).
The weakness of the respiratory musculature (with reduced strength and muscular 
resistance) “has signiﬁ  cant clinical consequences for COPD” (Decramer 2001) and 
this reason may partially explain the appearance of common symptoms like the effort 
dyspnea, hypercapnia, and reduced tolerance to physical exercise.
So far, a clinical study has demonstrated that respiratory muscle weakness is 
likely to increase health care resources and is correlated to reduced survival in COPD 
(Gray-Donald et al 1996). 
Respiratory muscle dysfunction is attributed to multiple factors related to the 
presence and severity of COPD. Indeed, intrinsic (muscular and metabolism mass) 
as well as extrinsic factors (changes in chest wall geometry and diaphragm position, 
and systemic metabolic factors) may alter respiratory muscle function (Gosselink et al 
2000). The mismatch between the demand for respiratory muscle work and the capacity 
to meet that demand is mainly caused by dynamic hyperinﬂ  ation (DH) produced by 
the incomplete emptying of the lungs during expiration. Hence, one of the most criti-
cal factors able to impair respiratory muscle function is the pulmonary hyperinﬂ  ation 
which induces the so-called intrinsic positive end expiratory pressure (PEEPi) generat-
ing an inspiratory threshold load which accounts for a higher ventilatory demand and 
a reduced tolerance during exercise. While inspiratory muscle weakness is at least International Journal of COPD 2007:2(1)  20
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partially attributed to hyperinﬂ  ation (placing the inspiratory 
muscles at a mechanical disadvantage), expiratory muscle 
weakness is a feature of the generalized myopathy observed 
in patients with COPD (Decramer 2001) including very low 
lactate threshold (Gallagher 1994) which in turn reduces 
muscle oxidative enzyme activities (Whittom et al 1998).
The most common forms of respiratory muscle training 
(RMT) generally include both inspiratory muscle training 
(IMT) and expiratory muscle training (EMT) component to a 
various extent. IMT assumes a prominent role in this type of 
training and the deﬁ  nitive role of EMT is still under debate. 
The positive inﬂ  uence of inspiratory muscle strengthen-
ing upon dyspnea is supported by observations on healthy 
young individuals (Volianitis et al 2001; Romer et al 2002) 
where pressure threshold IMT has also been associated 
with improved athletic performance. Two exhaustive meta-
analyses (Smith et al 1992; Lotters et al 2002) have collected 
available data from randomized trials focused on the effec-
tiveness of IMT in patients with COPD: results have shown 
a compelling body of evidence in favour of such training, 
so far included by the joint statement from the American 
College of Chest Physicians and American Association of 
Cardiovascular and Pulmonary Rehabilitation Committee 
(ACCP/AACVPR) among the recommended activities in 
the pulmonary rehabilitation programs (ACCP/AACVPR 
1997). In particular, it has also been demonstrated that plac-
ing a load on the respiratory muscle during contraction is 
sufﬁ  cient in increasing strength, thus causing a meaningful 
reduction of breathlessness and an increase of physical exer-
cise ability (Lotters et al 2002). Additionally, a more recent 
trial that evaluated the 1-year effects of IMT (Beckerman
et al 2005) provides evidence that IMT also decreases the use 
of healthcare services, which may translate into economic 
beneﬁ  ts as well. 
There is still debate in regards to which is the mechanism 
responsible for the enhanced inspiratory muscle force output 
(strength) following IMT. Some authors argue that inspira-
tory muscles of COPD patients are already well adapted 
to chronic loading and do not express any adaptation in 
response to training. Nonetheless, a substantial increase in 
the proportion of type I ﬁ  bers (by 38%) and in the size of 
type II ﬁ  bers (by 21%) of the external intercostal muscles 
have been found after IMT (Ramirez-Sarmiento et al 2002). 
These structural changes presumably represent adaptive 
effects with the genuine remodeling of inspiratory muscle 
structure during IMT.
In contrast with the plentitude of existing data inherent 
to IMT, the literature is still lacking in showing clinical and 
physiological studies related to EMT. The ﬁ  rst and complete 
study that explored the efﬁ  cacy of EMT has shown that the 
change in expiratory muscle strength and endurance and 
the six-minute walk distance were signiﬁ  cantly greater after 
EMT compared with controls; however, this advantage did 
not translate into any signiﬁ  cant change in the sensation 
of dyspnea during daily activities (Weiner et al 2003a). In 
another study EMT has been compared with both IMT and 
combined IMT+EMT, showing that there is no additional 
beneﬁ  t in including EMT to the training of the respiratory 
muscles (Weiner et al 2003b).
Overall, the inclusion of a speciﬁ  c RMT in a typical 
program focused on rehabilitation of symptomatic COPD 
is recommended. 
Patient selection
So far, the general guideline consensus (ACCP/AACVPR 
1997) indicated that RMT should be considered in “selected 
patients with inspiratory muscle weakness or with ventilatory 
limitation during physical activity, who remain symptomatic 
despite optimal therapy”. 
It appears obvious that providing IMT in a patient with 
maximal inspiratory pressure (MIP) below 60 cmH2O, can 
allow optimal beneﬁ  ts for that patient. However, adding 
IMT might also beneﬁ  t those patients with preserved and 
higher inspiratory muscular abilities. Similarly, highly 
trained athletes with MIP values above 120 cmH2O have also 
shown improvements in dyspnea and exercise performance 
(Volianitis et al 2001; Romer et al 2002). These data sup-
port the notion that since there are no known side-effects 
of IMT, this modality of training attenuates respiratory 
effort sensation irrespectively of the functional status of the 
inspiratory muscle. 
Thus it is likely that all the patients with symptomatic 
COPD (well-motivated patients with low response to other 
treatments) can beneﬁ  t from RMT. To conﬁ  rm this assump-
tion, the most recent consensus on pulmonary rehabilitation 
considers IMT as an “adjunctive therapy in pulmonary 
rehabilitation, primarily in patients with suspected or proven 
respiratory muscle weakness” (ATS/ERS 2006).
Although, RMT is associated with intra-thoracic decom-
pression, there are almost no side-effects associated with 
the training itself (Pardy et al 1988). Furthermore, patients 
with heart failure experience no deterioration of their cardiac International Journal of COPD 2007:2(1) 21
Respiratory muscles training in COPD patients
output during training. Hence, with the exception of patients 
with unstable asthma and low perception of dyspnea, a history 
of spontaneous pneumothorax or emphysema bubbles near 
pleura, there are no contraindications for IMT.
RMT can be delivered as an in-patient, out-patient, or 
domiciliary program setting, and it is typically administered 
and supervised by suitably trained physiotherapists. It may 
be implemented as a stand-alone intervention or as part 
of a comprehensive program of pulmonary rehabilitation. 
The domiciliary setting is generally the most convenient 
for the patient and it usually follows a period during which 
patients’ RMT is closely supervised in an in-patient or out-
patient clinic. Involvement of family members may also be 
beneﬁ  cial as they can provide encouragement and sustain 
patient’s motivation. 
Techniques
The three most common used modalities of RMT in patients 
with COPD are based on breathing against resistive loading 
(RL), breathing against pressure threshold loading (PTL) and 
voluntary normocapnic hyperpnea (NH). 
Resistive loading
This method requires individuals to inspire or expire via a 
variable-diameter oriﬁ  ce, whereby, for a given airﬂ  ow, the 
smaller the oriﬁ  ce the greater the load achieved. Although RL 
may improve respiratory muscle function (Aldrich and Kar-
pel 1985; Clanton et al 1985) conclusions from these studies 
should be interpreted with caution. A reasonable limitation of 
inspiratory RL is that inspiratory pressure, and consequently 
the training load, varies with ﬂ  ow rate according to a power 
function and not just to the oriﬁ  ce size (Pardy et al 1988). 
Therefore, it is crucial that the individual’s breathing pattern 
is monitored during training, thus allowing for the provision 
of a quantiﬁ  able training stimulus.
In their meta-analysis on IMT delivered on patients with 
COPD, Smith and coworkers (1992) concluded that the use 
of inspiratory RL without controlling the inspiratory ﬂ  ow 
rate fails to elicit signiﬁ  cant improvement in inspiratory 
muscle function. On the other hand, several studies which 
provided feedback control of ﬂ  ow rate during RL resulted in 
effective beneﬁ  ts, with particular regard to strength, dyspnea 
and physical exercise tolerance (Harver et al 1989; Belman 
and Mittman 1991; Sanchez Riera et al 2001). Nonetheless, 
such modiﬁ  cations require additional hardware, because of 
the increasing cost and complexity of this type of IMT.
Pressure threshold loading
This technique requires individuals to produce a negative pres-
sure sufﬁ  cient to overcome the load of the device and thereby 
initiate inspiration. Threshold loading allows variable loading 
at a detectable intensity by providing near ﬂ  ow independent 
resistance to inspiration. It has been achieved in several ways, 
by way of a weighted plunger (Nickerson and Keens 1982), 
a solenoid valve (Bardsley et al 1993), a constant negative 
pressure system (Chen et al 1998), or a spring-loaded poppet 
valve (Larson et al 1988; Gosselink et al 1996; Caine and 
McConnell 2000). The spring characteristics are linear such 
that a given change in spring length results in the same change 
in valve opening pressure at each spring length. The valve 
only opens when the inspiratory pressure generated by the 
patient exceeds the spring tension. Expiration is unimpeded 
and occurs via the expiratory ﬂ  ap valve. 
Threshold loading has been shown to induce improve-
ments in strength (Larson et al 1988; Lotters et al 2002), 
maximum rate of muscle shortening (Romer et al 2002; 
Villafranca et al 1998; Romer and McConnell 2003), maxi-
mum power output (Lisboa et al 1994; Villafranca et al 1998; 
Romer and McConnell 2003), and muscle endurance (Lisboa 
et al 1994; Weiner et al 2004). Due to its ﬂ  ow indepen-
dence, PTL training can be undertaken without monitoring 
the individual’s breathing pattern. In addition, PTL using a 
device with a mechanical poppet valve is both portable and 
easy to use, with evidence of efﬁ  cacy when implemented in 
a domiciliary setting, as well as in long-term use (see also 
Figure 1). To cut short, although it appears to be as effective 
as RL, PTL (probably due to its simplicity, reliability and 
“user-friendliness”) has been implemented most widely, 
especially using the poppet valve method. 
Voluntary normocapnic hyperpnea
To the best of our knowledge, the NH technique has been 
applied in very few studies (Belman and Mittman 1980; 
Levine et al 1986). This method requires individuals to 
maintain high target levels of ventilation up to 30 minutes. 
To prevent hypocapnia, subjects simply rebreathe through a 
dead space. Training sessions are typically conducted 3 to 5 
times per week at about 70%–90% of maximal sustainable 
voluntary ventilation and the training effect is evaluated by 
monitoring the change in the time to exhaustion during either 
sustained or incremental isocapnic ventilation. Because the 
complicated equipment needed to prevent hypocapnia this 
technique has usually been carried on in hospital facilities International Journal of COPD 2007:2(1)  22
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or research laboratory, and it has not been available for 
domiciliary purposes. 
Outcomes
Interpretation of the data relating to RMT in patients with 
COPD has been hampered by some studies with inadequate 
experimental designs; ﬂ  aws have often included a failure to 
apply basic training theories. The negative outcomes of most 
studies contributed to early scepticism about the value of 
RMT. However, in the overall assessment of the respiratory 
muscle training it is also important to consider both physi-
ological (eg, respiratory muscle strength and lung function) 
and clinical responses (eg, individual’s dyspnea, exercise 
tolerance, and even quality of life). 
From the individual’s functional ability, the efﬁ  cacy 
of RMT needs to be assessed in terms of inspiratory and 
expiratory muscle function. The most straight-forward non-
invasive assessment of respiratory muscle function are MIP 
and maximal expiratory pressure (MEP). These measures 
are indicative for weakness of the respiratory muscles and 
are indirectly assessed through the maximal and voluntary 
pressure generated during inspiration or expiration. To 
conﬁ  rm the importance of the appraisal of the respiratory 
muscle function measurements there are updated documents 
Figure 1 A threshold loading device practically adopted for inspiratory muscle training. International Journal of COPD 2007:2(1) 23
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in recent literature clarifying these aspects (ATS/ERS 2002; 
Troosters et al 2005). An argument favoring the use of MIP 
is that this functional improvement is linked to changes in 
dyspnea; additionally, it has been clearly deﬁ  ned that changes 
in dyspnea only occur when training results in improved 
muscle strength. This has been so far recognized in clinical 
trials (Harver et al 1989; Lisboa et al 1994). Regular monitor-
ing of MIP also provides both reassurance that patients are 
adhering to the prescribed training regimen, and the basis 
for resetting training loads: ideally, monitoring should be 
undertaken once per week. 
It is notable that a signiﬁ  cant positive relationship exists 
between the percentage increase in MIP and the relative 
magnitude of the IMT load (Pardy and Rochester 1992), thus 
suggesting that the higher the load relative to the subject’s 
inspiratory muscle strength, the greater is the increase in 
strength achieved. The existing data suggest that to achieve 
a 20% increase in MIP, a load of ≥30% MIP is then required 
(Lotters et al 2002). The lack of effectiveness of training at 
a load <30% of MIP is supported by previous observation 
(Presseur et al 1994) showing that MIP failed to improve 
signiﬁ  cantly after 12 weeks of IMT at a load equal to 22% 
of MIP. Reid has recommended the following parameters 
for IMT in COPD: an initial training interval as short as 3–5 
min, progressing to two 15 min or one 30 min session per 
day, 4–6 days per week at a training intensity of 40%–70% 
MIP indeﬁ  nitely (Reid et al 2004). Finally, more recent stud-
ies (Sturdy et al 2003; Hill et al 2006) have examined the 
feasibility of using high-intensity, interval-based threshold 
loading IMT (a total of about 20 minutes alternating cycles 
of 2-minutes of breathing at the maximum load tolerable, 
followed by 1 minute of rest). 
The results regarding duration of MIP’s improvements 
have been studied in only one randomized trial of IMT 
(Weiner et al 2004): in this study the largest improvement 
of MIP has been recorded during the ﬁ  rst 3 months of their 
study (32%), then followed by a smaller increase (~6%) 
in the four subsequent 3-month blocks of IMT. The early 
plateau effect of IMT has been observed so far in pathology 
(Larson et al 1988; Lisboa et al 1997) as well as in healthy 
individuals. The development of a plateau cannot be ascribed 
to a lack of load progression (increasing the training load to 
accommodate increases in MIP), since it occurs regardless 
of this measure. Instead, it is a reﬂ  ection of a basic property 
of muscle adaptation to strength training stimuli, which ne-
cessitates periodic changes in the training stimulus in order 
to maintain the adaptation process. Despite the now over-
whelming evidence that RMT, and particularly IMT using 
threshold loading, produces improvements in inspiratory 
muscle function, which in turn result in functional beneﬁ  ts to 
COPD patients, some researchers still ascribe these improve-
ments to mechanisms other than an adaptation to a training 
stimulus. Ramirez-Sarmiento and coworkers (2002) observed 
a signiﬁ  cant increase in the size of type 2 muscle ﬁ  bres 
taking biopsies from the external intercostals muscles fol-
lowing 5-week IMT; this is very strong evidence that IMT 
induces genuine remodeling of inspiratory muscles. 
Assessments of individual’s functional capacity (in terms 
of 6-minute or 12-minute walked distance) and dyspnea 
(BDI, TDI) are measures often associated with respiratory 
muscle strength recording. The effect of RMT by isocapnic 
hyperpnea in COPD patients has been translated into beneﬁ  ts 
of both respiratory muscle endurance and exercise tolerance, 
concluding that “respiratory muscle endurance training … 
improves health-related quality of life” (Scherer et al 2000). 
Similar ﬁ  ndings have been obtained using a target-ﬂ  ow incen-
tive spirometry system to train the inspiratory muscles, thus 
showing a signiﬁ  cant increase of the distance walked at 6 
months with respect to controls (Sanchez Riera et al 2001).
Signiﬁ  cant improvements are also evident in dyspnea and 
health-related quality of life. The beneﬁ  ts of RMT to respira-
tory breathlessness, exercise tolerance and quality of life were 
conﬁ  rmed in a recent published study of RMT by threshold 
loading method in severely impaired COPD patients (Covey 
et al 2001). The improvements in inspiratory muscle strength 
and endurance, paralleled the reduction in the sense of respira-
tory effort experienced during a loaded breathing task and in 
the respiratory symptoms associated with activities of daily 
living. These respiratory muscle function beneﬁ  ts have also 
been recently conﬁ  rmed in terms of 6-minute walked distance 
and quality of life by using a high-intensity, interval-based 
threshold loading IMT (Hill et al 2006).
Conclusions and clinical 
implications
Like other skeletal muscles, respiratory muscles undergo 
adaptation in response to stimuli overload during exercise 
training in stable COPD patients, thus resulting in signiﬁ  -
cant increases of strength and endurance and in a clinically 
signiﬁ  cant change of dyspnea sensation at rest and during 
exercise. Three types of RMT have been reported, (resis-
tive training, pressure threshold loading, and normocapnic 
hyperpnea) with no data, at present, to support one method 
over the other.International Journal of COPD 2007:2(1)  24
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For a training effect, the frequency, duration, and inten-
sity of exercise must be considered. A number of factors are 
associated with successful outcomes after RMT; a training 
frequency of 1–2 times per day for a total amount of 30 
minutes, with a frequency of 3–5 days per week for a dura-
tion of 6 weeks has been suggested and may induce desired 
changes. With concern to the inspiratory load, the evidence 
supports the use of training loads that exceed 30% of MIP 
with a repetition duration dependent upon the load, as higher 
loads cannot be sustained as long as lower loads.  
While it seems that IMT is slightly superior to EMT 
in providing additional benefit other than respiratory 
muscle function such as a reduction in dyspnea, the 
effects and the safety of EMT in patients with COPD is yet 
to be elucidated. 
Therefore, actual evidence for RMT, in addition to 
regular exercise training in stable COPD patients with or 
without respiratory muscle weakness, needs to be further 
implemented. 
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